BlackRock, Inc. 13D and 13G filings for Lyell Immunopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-05 1:23 pm Sale |
2024-12-31 | 13G | Lyell Immunopharma, Inc. LYEL |
BlackRock Inc. BLK |
663,293 4.500% |
-51,818 (-7.25%) |
Filing |
| 2024-01-29 5:25 pm Purchase |
2023-12-31 | 13G | Lyell Immunopharma, Inc. LYEL |
BlackRock Inc. BLK |
715,111 5.700% |
715,111 (New Position) |
Filing |